Huashan Lin

机构：General Electric (Spain), Department of Pharmaceuticals · ORCID：0000-0002-1274-1709

发表论文 46 篇 · 总被引 530 次 · h-index 13

代表论文

• Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer (2023 · Frontiers in Immunology · 被引 69)
• Nomogram based on clinical and preoperative CT features for predicting the early recurrence of combined hepatocellular-cholangiocarcinoma: a multicenter study (2023 · La radiologia medica · 被引 19)
• The value of radiomics-based CT combined with machine learning in the diagnosis of occult vertebral fractures (2023 · BMC Musculoskeletal Disorders · 被引 17)
• Application of DCE-MRI radiomics signature analysis in differentiating molecular subtypes of luminal and non-luminal breast cancer (2023 · Frontiers in Medicine · 被引 17)
• Development and validation of a MRI-based combined radiomics nomogram for differentiation in chondrosarcoma (2023 · Frontiers in Oncology · 被引 13)
• Development of MRI-based radiomics predictive model for classifying endometrial lesions (2023 · Scientific Reports · 被引 11)